---
title: "Selected Cannabis Exempt from Certain Medicines Act"
description: "On 23 May 2019, the department of Health published Government Notice No. 42477 wherein the then Minister of Health, Dr Aaron Motsoaledi"
image: https://spoor.com/wp-content/uploads/2019/08/Cape-Town-1.jpeg
canonical: https://spoor.com/zh/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/
url: https://spoor.getmd.ai/zh/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/.md
last_converted: 2026-07-28T00:30:56.984Z
---

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Article",
      "@id": "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/#article",
      "isPartOf": {
        "@id": "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/"
      },
      "author": {
        "name": "Dirk Hanekom and Natalie Slabbert",
        "@id": "https://spoor.com/#/schema/person/6141ba5e6eb5af2bf8c75cb2f31dcaa1"
      },
      "headline": "South Africa: Selected Cannabis Preparations Now Excluded from Certain Provisions of the Medicines and Related Substances Act",
      "datePublished": "2019-08-05T08:04:01+00:00",
      "dateModified": "2025-01-14T19:36:41+00:00",
      "mainEntityOfPage": {
        "@id": "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/"
      },
      "wordCount": 310,
      "commentCount": 0,
      "publisher": {
        "@id": "https://spoor.com/#organization"
      },
      "image": {
        "@id": "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/#primaryimage"
      },
      "thumbnailUrl": "https://spoor.com/wp-content/uploads/2019/08/Cape-Town-1.jpeg",
      "articleSection": [
        "News Update"
      ],
      "inLanguage": "zh-Hans",
      "potentialAction": [
        {
          "@type": "CommentAction",
          "name": "Comment",
          "target": [
            "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/#respond"
          ]
        }
      ]
    },
    {
      "@type": "WebPage",
      "@id": "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/",
      "url": "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/",
      "name": "Selected Cannabis Exempt from Certain Medicines Act",
      "isPartOf": {
        "@id": "https://spoor.com/#website"
      },
      "primaryImageOfPage": {
        "@id": "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/#primaryimage"
      },
      "image": {
        "@id": "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/#primaryimage"
      },
      "thumbnailUrl": "https://spoor.com/wp-content/uploads/2019/08/Cape-Town-1.jpeg",
      "datePublished": "2019-08-05T08:04:01+00:00",
      "dateModified": "2025-01-14T19:36:41+00:00",
      "description": "On 23 May 2019, the department of Health published Government Notice No. 42477 wherein the then Minister of Health, Dr Aaron Motsoaledi",
      "breadcrumb": {
        "@id": "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/#breadcrumb"
      },
      "inLanguage": "zh-Hans",
      "potentialAction": [
        {
          "@type": "ReadAction",
          "target": [
            "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/"
          ]
        }
      ]
    },
    {
      "@type": "ImageObject",
      "inLanguage": "zh-Hans",
      "@id": "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/#primaryimage",
      "url": "https://spoor.com/wp-content/uploads/2019/08/Cape-Town-1.jpeg",
      "contentUrl": "https://spoor.com/wp-content/uploads/2019/08/Cape-Town-1.jpeg",
      "width": 1400,
      "height": 250,
      "caption": "Beautiful view of Table Mountain in Cape Town from Signal Hill and some light streeks from cars."
    },
    {
      "@type": "BreadcrumbList",
      "@id": "https://spoor.com/south-africa-selected-cannabis-preparations-now-excluded-from-certain-provisions-of-the-medicines-and-related-substances-act/#breadcrumb",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://spoor.com/"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "South Africa: Selected Cannabis Preparations Now Excluded from Certain Provisions of the Medicines and Related Substances Act"
        }
      ]
    },
    {
      "@type": "WebSite",
      "@id": "https://spoor.com/#website",
      "url": "https://spoor.com/",
      "name": "Spoor & Fisher",
      "description": "",
      "publisher": {
        "@id": "https://spoor.com/#organization"
      },
      "potentialAction": [
        {
          "@type": "SearchAction",
          "target": {
            "@type": "EntryPoint",
            "urlTemplate": "https://spoor.com/?s={search_term_string}"
          },
          "query-input": {
            "@type": "PropertyValueSpecification",
            "valueRequired": true,
            "valueName": "search_term_string"
          }
        }
      ],
      "inLanguage": "zh-Hans"
    },
    {
      "@type": "Organization",
      "@id": "https://spoor.com/#organization",
      "name": "Spoor & Fisher",
      "url": "https://spoor.com/",
      "logo": {
        "@type": "ImageObject",
        "inLanguage": "zh-Hans",
        "@id": "https://spoor.com/#/schema/logo/image/",
        "url": "https://spoor.com/wp-content/uploads/2022/08/200210-SP-Logo_RGB-01-screen-scaled.jpg",
        "contentUrl": "https://spoor.com/wp-content/uploads/2022/08/200210-SP-Logo_RGB-01-screen-scaled.jpg",
        "width": 2560,
        "height": 813,
        "caption": "Spoor & Fisher"
      },
      "image": {
        "@id": "https://spoor.com/#/schema/logo/image/"
      },
      "sameAs": [
        "https://www.facebook.com/spoorfisher/",
        "https://x.com/spoorfisher"
      ]
    },
    {
      "@type": "Person",
      "@id": "https://spoor.com/#/schema/person/6141ba5e6eb5af2bf8c75cb2f31dcaa1",
      "name": "Dirk Hanekom and Natalie Slabbert",
      "image": {
        "@type": "ImageObject",
        "inLanguage": "zh-Hans",
        "@id": "https://secure.gravatar.com/avatar/b7022085f56c7c4b0ce2c47d9e950f564f9d42720d3daeef8dc66d84a8506100?s=96&d=mm&r=g",
        "url": "https://secure.gravatar.com/avatar/b7022085f56c7c4b0ce2c47d9e950f564f9d42720d3daeef8dc66d84a8506100?s=96&d=mm&r=g",
        "contentUrl": "https://secure.gravatar.com/avatar/b7022085f56c7c4b0ce2c47d9e950f564f9d42720d3daeef8dc66d84a8506100?s=96&d=mm&r=g",
        "caption": "Dirk Hanekom and Natalie Slabbert"
      }
    }
  ]
}
```

[家](https://spoor.com)
› [知识中心](https://spoor.com/knowledge-centre/)
›
[法律更新/](https://spoor.com/zh/knowledge-centre/legal-updates/)

›
南非：选定的大麻制剂现已排除在《药品和相关物质法》的某些条款之外

# 南非：选定的大麻制剂现已排除在《药品和相关物质法》的某些条款之外

德克·哈内科姆和娜塔莉·斯拉伯特
- 5 8 月 2019

### 2019 年 5 月 23 日，卫生部发布了第 42477 号政府公告，其中时任卫生部长 Aaron Motsoaledi 博士将某些含有大麻二酚 (CBD) 的制剂排除在《药品和相关物质管制》第 22A(2) 条的操作之外1965 年第 101 号法案（“法案”）。

就本通知而言，任何含有 CBD 的制剂：

- 每日最大剂量为 20 毫克 CBD 且可接受的低风险声明，或仅指一般健康增强、健康维护或轻微症状缓解（与疾病无关）的健康声明；或者

- 由植物原料制成的加工产品组成，其中产品中的大麻素是天然存在的，总四氢大麻酚 (THC) 含量不超过 0.001 %，总 CBD 含量不超过 0.0075 %；

被排除在该法第 22A(2) 条的实施之外。

该法案第 22A(2) 条规定，卫生部长可以宣布某些产品为计划药品。

这意味着任何含有每日 CBD 剂量不超过 20 毫克并具有低风险健康声明的产品；或者由生大麻植物的加工产品组成，其中 CBD 和 THC 的水平非常低，不是预定的药物。

这使得这些产品的制造、销售、购买、拥有和消费都是合法的。

市场上已有此类产品的例子包括某些供人类和动物使用的大麻油，用于在治疗某些疾病期间提供对症支持；供人类和动物使用的肥皂、乳液、洗发水、药膏和其他盥洗用品；以及作为营养支持销售的含有 CBD 的糖果和薄荷糖等。

最新的通知为快速增长的大麻产业的特定部分提供了一些急需的清晰度。